Clinical Trials Directory

Trials / Completed

CompletedNCT05050877

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention - Cardiorenal ImprovemeNt Registry II

Status
Completed
Phase
Study type
Observational
Enrollment
184,855 (actual)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

As a multi-center, retrospective observation study in southern China, this study included the main study population of patients who underwent coronary angiography at 5 hospitals from Guangzhou, Shenzhen, Yangjiang, Maoming and Longyan from January 2000 to Decemeber 2020. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient system. Data on all-cause death were obtained from the Guangdong Provincial Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Detailed description

This is a multi-center, retrospective observation study collecting data on 184855 coronary angiography patients from January 2000 to Decemeber 2020. Data regarding demographic information, admission diagnoses and history of present illness, biomarkers and details on preventive hydration and medications will be collected. The primary endpoint of this study is Adverse Cardiovascular and Kidney Events.

Conditions

Timeline

Start date
2000-06-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2021-09-21
Last updated
2021-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05050877. Inclusion in this directory is not an endorsement.